A new approach for modeling patient overall radiosensitivity and predicting multiple toxicity endpoints for breast cancer patients.
Authors
Mbah, CDe Ruyck, K
De Schrijver, S
De Sutter, C
Schiettecatte, K
Monten, C
Paelinck, L
De Neve, W
Thierens, H
West, Catharine M L
Amorim, G
Thas, O
Veldeman, L
Affiliation
Department of Radiotherapy and Experimental Cancer Research , Ghent University , Ghent , BelgiumIssue Date
2018-01-04
Metadata
Show full item recordAbstract
Evaluation of patient characteristics inducing toxicity in breast radiotherapy, using simultaneous modeling of multiple endpoints.Citation
A new approach for modeling patient overall radiosensitivity and predicting multiple toxicity endpoints for breast cancer patients. 2018:1-9 Acta OncolJournal
Acta OncologicaDOI
10.1080/0284186X.2017.1417633PubMed ID
29299946Type
ArticleLanguage
enISSN
1651-226Xae974a485f413a2113503eed53cd6c53
10.1080/0284186X.2017.1417633
Scopus Count
Collections
Related articles
- In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
- Authors: Vandevoorde C, Depuydt J, Veldeman L, De Neve W, Sebastià N, Wieme G, Baert A, De Langhe S, Philippé J, Thierens H, Vral A
- Issue date: 2016 Dec
- Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies.
- Authors: Barnett GC, West CM, Coles CE, Pharoah PD, Talbot CJ, Elliott RM, Tanteles GA, Symonds RP, Wilkinson JS, Dunning AM, Burnet NG, Bentzen SM
- Issue date: 2012 Mar 1
- Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: a randomized study between electron and photon.
- Authors: Rajan SS, Sharma SC, Kumar N, Kumar R, Singh G, Singh R, Tomar P
- Issue date: 2014 Oct-Dec
- Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
- Authors: Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Uter W, Strnad V, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO).
- Issue date: 2017 Feb
- Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
- Authors: Bentzen SM, Overgaard M, Overgaard J
- Issue date: 1993